treatment options in refractory mcrc
Published 6 years ago • 273 plays • Length 7:32Download video MP4
Download video MP3
Similar videos
-
3:04
treatment goals in refractory mcrc
-
7:35
use of regorafenib in refractory mcrc
-
4:26
sequencing of therapy in refractory mcrc
-
6:24
immunotherapy options in refractory crc
-
8:34
relapsed/refractory mcrc: immunotherapy in msi-high tumors
-
6:54
treatment approach in colorectal cancer refractory setting
-
3:24
'tumors just vanished': cancer patients now in remission after drug trial
-
10:09
treatment of metastatic colon cancer - sarah cannon
-
6:53
is stage 4 metastatic colorectal cancer manageable: role of targeted therapy in mcrm
-
37:22
eha 2024 recap: optimizing the relapsed/refractory cll treatment pathway
-
6:34
therapeutic agents in relapsed/refractory mcrc
-
8:04
first- and second-line treatment for mcrc in specific populations
-
0:57
dr. cercek on the need for treatment options in kras mutated mcrc
-
4:58
tas-102 in refractory metastatic colorectal cancer
-
6:04
third-line treatment in refractory crc
-
7:35
treatment options for third-line therapy in mcrc
-
3:35
#esmo22 highlights on the efficacy and safety of fruquintinib in refractory mcrc: the fresco-2 study
-
5:29
changing realities in treating mcrc
-
5:02
third-line treatment options for mcrc
-
5:56
molecular status and subsequent therapies in mcrc
-
7:15
salvage therapy options for mcrc